Drug & intervention

nelfinavir

RxCUI 134527

Clinical trials14
Recruiting0
Related conditions12
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Nelfinavir

Nelfinavir, sold under the brand name Viracept, is an antiretroviral medication used in the treatment of HIV/AIDS. Nelfinavir belongs to the class of drugs known as protease inhibitors (PIs) and, like other PIs, it is almost always used in combination with other antiretroviral drugs. Nelfinavir is an orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki = 2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection. It was patented in 1992 and approved for medical use in 1997.

Read on Wikipedia ↗ Wikidata Q423366 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

14 shown
Radical Lung Radiotherapy Plus NelfinavirNCT01447589 · 2012-02-01
WITHDRAWN
Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)NCT01108666 · 2010-03-01
TERMINATED
Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and NeckNCT01065844 · 2009-10-01
COMPLETED
Evaluation of Nelfinavir and Chemoradiation for Pancreatic CancerNCT01086332 · 2009-05-01
TERMINATED
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung CancerNCT00791336 · 2008-08-01
TERMINATED
A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid TumorsNCT01445106 · 2006-12-11
COMPLETED
When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)NCT00234091 · 2006-04-01
COMPLETED
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVNCT00307502 · 2005-01-01
COMPLETED
Nelfinavir and M8 Drug-level Monitoring in HIV-1 InfectionNCT00205283 · 2003-08-01
COMPLETED
The Effects of HIV Protease Inhibitors in Severe SepsisNCT00346580 · 2003-06-01
COMPLETED
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)NCT00192660 · 2003-02-01
COMPLETED
Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)NCT00122590 · 2002-07-01
TERMINATED
Mechanisms of Lipodystrophy in HIV-Infected PateintsNCT00457665 · 2002-02-01
COMPLETED
TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TBNCT00023400 · 2000-02-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.